Share This Author
Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database
- James R. Williams, David Fitzhenry, Lauren Grant, Derek C. Martyn, D. Kerr
- Medicine, PsychologyBMC Neurology
- 4 November 2013
A diagnostic delay for patients with ALS in the US Medicare population is described, similar to previous reports, and motor nerve conduction testing in patients with bulbar-onset ALS had the largest impact on time to diagnosis.
Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats
- Derek C. Martyn, L. Meckley, M. Corral
- MedicineClinicoEconomics and outcomes research : CEOR
- 6 November 2015
Comparing the outcomes of health care resource utilization (HRU) and costs associated with using ORCs compared to other adjunctive hemostats for surgical procedures in the US inpatient setting found hemostatic agent costs were lower than or similar to patients treated with OAHs.
Current and Future Disease Progression of the Chronic HCV Population in the United States
It is found that the total diagnosed chronic HCV population grew from 983,000 to 1.19 million in 2007–2009, with patients born from 1945–1964 accounting for 75.0% of all patients, 83% of AdvLD patients, and 79.2% of costs in 2009, indicating that HCV is primarily a disease of the “baby boomer” population.
Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures
In a retrospective hospital database analysis, the use of SAPs were associated with lower healthcare resource utilization and costs compared to SO.